SMARCA4 mutations are also associated with Wilms tumors (Rakheja et al., 2014; Treger et al., 2019), a type of renal cancers that accounts for nearly 90% of renal tumors in children and 7% of all childhood cancers (Breslow et al., 1993). Here, SMARCA4 is linked to renal carcinoma.